Serval Inc. Announces $150 Million Securities Offering
Serval Inc. files for a $150 million securities offering, nearing completion with strong investor interest. A significant move for the tech sector.
JPMorgan Chase Financial Co. files for Step-Up Auto Callable Notes
JPMorgan Chase Financial Co. LLC files a preliminary pricing supplement for Step-Up Auto Callable Notes, guaranteed by JPMorgan Chase & Co.
Morgan Stanley Finance LLC Files Pricing Supplement for Notes
Morgan Stanley Finance LLC has filed a pricing supplement for market-linked notes due in 2030, reflecting its strategy in the competitive financial industry.
Barclays Bank unveils new contingent coupon notes
Barclays Bank PLC has filed for new Autocallable Buffered Contingent Coupon Notes, signaling innovation in structured finance products.
JPMorgan Chase Financial Co. files for new structured notes
JPMorgan Chase Financial Co. LLC files a preliminary pricing supplement for new structured investment notes, signaling innovation in the banking sector.
Twist Bioscience Officer Files to Sell Shares Amid Activity
Robert F. Werner of Twist Bioscience Corp files to sell shares, reflecting ongoing insider trading activity in the biotechnology sector.
Morgan Stanley Finance LLC Files Pricing Supplement for New Investment
Morgan Stanley Finance LLC has filed a pricing supplement for a new structured investment product, reflecting its commitment to innovative financial solutions.
JPMorgan Chase Financial Co. launches new Digital Equity Notes
JPMorgan Chase Financial Co. LLC has filed a pricing supplement for Digital Equity Notes linked to the TOPIX Index, reflecting innovation in the banking sector.
Wooldridge reports acquisition of shares in UFP Industries
Michael G. Wooldridge discloses acquisition of 406 shares in UFP Industries Inc., bringing total holdings to 16,189 shares as of November 2, 2026.
Henry Schein reports Q3 results with continued growth
Henry Schein Inc. reports strong Q3 results, reflecting growth in the wholesale medical, dental, and hospital equipment sector amid ongoing challenges.
SPDR Series Trust Updates Investment Strategies in New Filing
SPDR Series Trust updates its investment strategies and fund offerings in a recent filing, reflecting changes in market conditions and investor needs.
JPMorgan Chase Financial Co. files pricing supplement for notes
JPMorgan Chase Financial Co. LLC files a pricing supplement for $14.76 million in structured investments, signaling growth in the banking sector.
AuguStar Variable Account A Announces Portfolio Reorganizations
AuguStar Variable Account A has approved three reorganizations for its variable annuity contracts, aiming to optimize portfolio offerings and expenses.
Lear Corp officer Jason M. Cardew files to sell 5,000 shares
Jason M. Cardew of Lear Corp has filed to sell 5,000 shares of common stock, valued at approximately $588,736.09, following recent stock vesting.
Barclays Bank unveils callable contingent coupon notes
Barclays Bank PLC has announced a new offering of callable contingent coupon notes due November 14, 2031, enhancing its capital strategy.
Coastlands Capital Partners amends private offering details
Coastlands Capital Partners LP has amended its private offering under Rule 506(b), reflecting ongoing strategies in the hedge fund industry.
BofA Finance announces $2.45 billion yield notes issuance
BofA Finance LLC files for $2.45 billion yield notes guaranteed by Bank of America, reflecting innovation in national commercial banks sector.
JPMorgan Chase Financial files pricing supplement for notes
JPMorgan Chase Financial Co. LLC files a pricing supplement for $1,094,000 in digital barrier notes linked to major stock indices, signaling innovation in banking.
Barclays Bank announces Buffered Supertrack Notes offering
Barclays Bank PLC files preliminary pricing supplement for Buffered Supertrack Notes linked to the S&P 500 Index, enhancing its product offerings.
Green Paula sells 1,007 shares of Twist Bioscience stock
Green Paula sold 1,007 shares of Twist Bioscience stock for $136,349.51, part of ongoing compensation adjustments in the life sciences sector.